Melanotan-2 Results: Week-by-Week Timeline (2026)

Months 1-2: Full Tan and Maintenance Transition

By 4-8 weeks of loading, most users have reached or are approaching their desired pigmentation level. This is the transition point from loading to maintenance dosing.

What to Expect

Full tan established for Type III-IV users (typically by week 4-5). Type I-II users may need the full 6-8 weeks.

Color stabilization — the tan looks more even and natural as melanin distribution equalizes across skin areas.

Maintenance transition — loading dose (daily 250-500mcg) shifts to maintenance (500mcg 1-2x per week). Some users maintain on even less frequent dosing.

Side effects at maintenance are minimal. Nausea is typically absent at this stage. Appetite effects and sexual effects persist but are milder with less frequent dosing.

Mole monitoring remains critical. A qualitative study of MT-2 users found that mole darkening and new mole formation were among the most commonly reported longer-term effects (Evans-Brown et al., 2021). A dermatological skin check is the documented precaution at this stage.

Maintenance Dosing Protocol

The goal of maintenance is to sustain melanin levels with the minimum effective dose:

Type I-II

500mcg

2x per week

Type III-IV

250-500mcg

1-2x per week

Type V-VI

250mcg

1x per week or less

With consistent UV exposure (even incidental), many users find they can reduce maintenance frequency over time. Without UV, maintenance doses need to be more frequent to preserve pigmentation.

Months 3+: Long-Term Considerations

Users on long-term MT-2 maintenance report stable tanning results with minimal side effects. However, several long-term considerations deserve attention.

Sustained Effects

Tan quality improves over months as melanin distribution becomes more uniform.

Dose requirements may decrease. Many long-term users find they need less frequent maintenance dosing over time.

Seasonal adjustment — users in northern latitudes with minimal winter UV may need slightly higher maintenance frequency in winter months, or accept some fading.

Safety Monitoring

Dermatological screening every 3-6 months is the commonly documented precaution during active use. At least one case report has documented melanoma emergence during MT-2 use in combination with tanning bed exposure (Reid et al., 2013). While causation was not established, melanocyte stimulation warrants ongoing vigilance.

Mole tracking using the ABCDE criteria (asymmetry, border, color, diameter, evolving) is the documented approach; baseline photographs allow comparison.

Blood pressure monitoring — MT-2 can cause transient blood pressure elevations. See the Melanotan-2 bloodwork guide for the full monitoring panel.

What Happens After Stopping

Week 1-2 after stopping: No immediate visible change. Melanin already deposited in the skin remains.

Weeks 2-4: Gradual fading begins as natural skin cell turnover replaces pigmented cells.

Weeks 4-8: Most of the MT-2 enhanced tan has faded. Rate depends on skin type and ongoing UV exposure.

Full return to baseline: 2-3 months for most users, though some report residual pigmentation lasting longer, particularly in freckles.

Factors That Affect Results

1. Fitzpatrick Skin Type (Biggest Factor)

Genetic melanocyte density and melanin type (eumelanin vs. pheomelanin) determine the ceiling and speed. Type I skin has a fundamentally lower ceiling than Type IV — MT-2 cannot override genetics, only optimize the existing capacity.

2. UV Exposure

The single most controllable accelerator. Even brief, regular UV exposure (10-15 minutes of sunlight) dramatically outperforms zero UV. However, the goal is activation, not sunburn. Burning while on MT-2 is still burning — the peptide provides some photoprotective benefit but does not confer immunity to UV damage.

3. Dose and Consistency

Daily dosing during loading matters more than high individual doses. A consistent 250mcg daily protocol will outperform sporadic 500mcg doses. Missing days extends the loading timeline proportionally.

4. Injection Site and Method

Subcutaneous injection is the standard route. Nasal spray formulations exist but have significantly lower bioavailability and less predictable absorption. Slow results on nasal MT-2 may trace to this.

See the Melanotan-2 reconstitution guide for proper preparation.

5. Body Area

Areas with higher melanocyte density (face, shoulders, forearms) tan first and fastest. Torso, legs, and areas typically covered by clothing lag behind. Areas that receive direct UV exposure will always outpace covered areas.

Results by Use Case

MT-2 activates multiple melanocortin receptors, producing effects beyond skin tanning.

Tanning (MC1R)

This is the primary use case and follows the timeline above. Peak tanning results typically occur at 4-6 weeks for most skin types.

Sexual Function (MC4R)

Sexual effects are among the earliest and most consistent MT-2 responses. In a double-blind placebo-controlled trial, MT-2 initiated erections in 17 of 20 men with erectile dysfunction, and 68% reported increased sexual desire versus 19% on placebo (Wessells et al., 2000).

Timeline:

First dose: Many users report increased libido and spontaneous erections within 1-5 hours of the first injection.

Loading phase: Effects are consistent with each dose. They typically begin 1-3 hours post-injection and last 4-8 hours.

Maintenance: Sexual effects persist but are less intense with lower dosing frequency. They tend to correlate directly with dose timing.

Appetite Suppression (MC4R)

MT-2's anorectic effect is mediated through the same MC4R pathway that regulates satiety. Animal studies show significant food intake reduction with intermittent MT-2 dosing, with robust fat loss that persists even after food intake normalizes (Grieco et al., 2010).

First dose: Appetite suppression is noticeable from day one for most users.

Weeks 1-2: Strongest appetite suppression during daily loading. Some users report difficulty eating enough.

Weeks 3-4: Partial tolerance develops. Appetite suppression is still present but less dramatic.

Maintenance: Effects diminish with less frequent dosing. This is primarily a loading-phase benefit.

When to Adjust the Protocol

Signs It Is Working

Freckle and mole darkening within the first week

Gradual, progressive skin darkening (not overnight)

Mild side effects (nausea, flushing) that decrease over days

Noticeable tan difference between UV-exposed and covered areas

Signs to Reassess

No visible change after 3 weeks of consistent loading (Type III+): common troubleshooting steps described by community sources are checking product quality, confirming UV exposure, and confirming reconstitution was done correctly.

No change after 4-5 weeks (Type I-II): community sources describe increasing the loading dose to 500mcg if tolerated. Some very fair-skinned individuals self-report needing higher cumulative doses.

Severe or worsening side effects: see the Melanotan-2 side effects guide for red flags.

New moles or changing moles: dermatological evaluation is the documented response, regardless of how the tan is progressing.

Unusual symptoms (severe headache, chest pain, vision changes): rare but serious adverse events including rhabdomyolysis have been reported (Hjuler & Bhalla, 2012).

When to Stop

There is no established maximum duration for MT-2 use. However, reasonable stopping points include:

Goal achieved: the desired tan level is reached and can be maintained with minimal dosing.

Mole concerns: Any dermatological findings that warrant discontinuation.

Side effect burden: If side effects are not acceptable even at low doses.

Seasonal: Some users cycle MT-2 only during spring/summer and allow the tan to fade in winter.